William Steinkohl, MD
Urology · Henderson, NVNPI 1689769440
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $840 of the $1,130 with a category attached, or 74.3%. 13 manufacturers reported payments, led by Astellas Pharma US Inc at 33.3% of the total. Reporting peaked in 2019 at $462 and has fallen 88.9% since, to $51 in 2025. That places this record below the midpoint for urology clinicians in NV, where the typical reported total is $2,990.
Across 36 payments — averaging $31.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$376
- Boston Scientific$178
- Procept Biorobotics Corporation$159
- AbbVie$117
- 180 Medical, Inc.$87
- Urogen Pharma, Inc.$68
- plus $145 from 7 others
What the payments were for
- Food & beverage$84074%
- Education$29026%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 14 | $376 |
| Boston Scientific | 3 | $178 |
| Procept Biorobotics Corporation | 1 | $159 |
| AbbVie | 1 | $117 |
| 180 Medical, Inc. | 4 | $87 |
| Urogen Pharma, Inc. | 3 | $68 |
| Olympus America Inc. | 1 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Laborie Medical Technologies Corp. | 4 | $23 |
| Merck | 1 | $23 |
| Coloplast | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $12 |
| Axonics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$159
- BOTOX$117
- GENERAL BPH$107
How this compares
$1,130 in reported general payments places this provider in the 25th percentile of 63 urology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 189 | $126,198 |
| GemtesaVibegron | 36 | $33,721 |
| Tamsulosin Hcl | 1,590 | $20,526 |
| Testosterone | 29 | $10,137 |
| Oxybutynin Chloride ErOxybutynin Chloride | 310 | $6,397 |
| NitrofurantoinNitrofurantoin Macrocrystal | 216 | $4,940 |
| Finasteride | 424 | $4,146 |
| Testosterone Cypionate | 47 | $2,770 |
| Potassium Citrate ErPotassium Citrate | 23 | $2,359 |
| Cephalexin | 242 | $2,032 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 107 | $1,813 |
| Silodosin | 15 | $1,785 |
| Methenamine Hippurate | 24 | $1,740 |
| Solifenacin Succinate | 52 | $1,628 |
| Desmopressin Acetate | 13 | $1,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $376 | $126,198189 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $24 | $33,72136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 63 urology providers in Nevada.
Other urology in Henderson
- Casey McCrawHenderson$23K
- Guillermo PatinoHenderson$15K
- Scott BaranoffHenderson$7K
- Jeffrey ZapinskyHenderson$7K
- Michael FinkelsteinHenderson$3K
- Adam RussonHenderson$2K
- Ralph LarsenHenderson$2K
- Eliot HorowitzHenderson$125
- Christopher EvansReno$184K
- Vijay GoliLas Vegas$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.